1. Experience in the clinical use of allogeneic fibroblasts in patients with severe burns
- Author
-
Evgenij V. Zinoviev, Yurij V. Yurkevich, Pavel K. Krylov, Vitalij V. Soloshenko, Konstantin M. Krylov, Natalia Mikhailova, Miralda I. Blinova, Denis V. Kostyakov, Denis O. Vagner, N. I. Enukashvily, and Olga I. Aleksandrova
- Subjects
medicine.medical_specialty ,lcsh:R5-920 ,business.industry ,wound ,surgical treatment ,cellular technology ,Healing time ,Surgery ,Transplantation ,skin graft ,fibroblasts ,Medicine ,burn ,Severe burn ,In patient ,business ,Surgical treatment ,lcsh:Medicine (General) - Abstract
Purpose. To evaluate the results of the application of allogenic fibroblasts in patients with extensive thermal burns. Methods. The study included 34 patients with burns over 20% TBSA, treated in the burn ICU. In accordance with the indications for transplantation of fibroblasts, all patients were divided into 4 groups: stimulation of regeneration of superficial burns (n = 10), stimulation of regeneration after meshed skin graft (n = 14), reduction of healing time for donor wounds (n = 6) and acceleration growth of granulations after the escharectomy (n = 4). Results. A positive effect of fibroblast transplantation was found in 7 (70%) patients of the first group, 13 (93%) of the patients in the second group, 2 (33%) of the third group and 2 (50%) in the fourth study group. Conclusion. The maximum positive effect of transplantation of human dermal fibroblasts can be observed when performing the meshed skin graft and treating the superficial burns.
- Published
- 2018